September 17-19, 2013
Ocean Place Resort & Spa (no hurricane damage)

New in 2013

Beach Party (20 sec)

NEW IN 2013 BY ATTENDEE REQUEST:

  • Conference sessions will take place in re-designed exhibit halls to bring buyers and suppliers together all day, every day
  • 3 full days instead of 4 (September 17-19, 2013)
  • Portable meeting rooms in exhibit halls for exclusive exhibitor use only
  • Exhibit Hall roundtables, reception, raffles, and other ongoing activities all day, every day, to attract attendees
  • New, business-critical topics for panels and talks
  • More stand alone talks and high profile keynote speakers
  • One day low cost pass to attract new participants
  • One week later than usual to attract more attendees
  • Lower rate for Pharmaceutical Co. end users and other "buyers"

ChemOutsourcing is the largest USA-based API show attracting annually 700-800 chemists from the pharmaceutical, biotech, and chemical industries. The show focuses on API development spanning early drug discovery through chemical development and commercial supply. Attendees are executive scientists from pharmaceutical companies responsible for sourcing starting materials, intermediates, and Active Ingredients, and experienced in working with Contract Research and Contract Manufacturing Organizations. Likewise, the show is heavily attended by high-level executive suppliers of these services and products, including 100+ exhibitors. The show is further distinguished by its accessible buyers and upscale seaside venue.

ChemOutsourcing in the News!

Thursday, May 25, 2013, List of Buyer Companies Already Registered to Attend

Abbott Labs
AbbVie (5)
Aegerion Pharmaceuticals (2)
Alvogen
Amicus Therapeutics (2)
Amgen (3)
Ariad Pharmaceuticals
Arno Therapeutics
ArQule
Array BioPharma
AstraZeneca Neuroscience
AstraZeneca Pharmaceuticals
Axikin Pharmaceuticals
Bayer Healthcare
BioNumerick Pharmaceuticals
Bristol-Myers Squibb (10)
Boehringer Ingelheim Pharmaceuticals (4)
Cardioxyl Pharmaceuticals
Celgene Corporation
Celgene Avilomics Research
Concert Pharmaceuticals, Inc.
Cubist Pharmaceuticals (2)
Curis, Inc.
Cytokinetics
DuPont Crop Protection
Eli Lilly & Company (4)
Ember Therapeutics
Exelixis, Inc.
F. Hoffmann-La Roche
Fibrogen, Inc.
Forest Labs (2)
Galleon Pharmaceuticals
Genentech (3)
Gilead Sciences (3)
GlaxoSmithKline (4)
GlycoMimetics, Inc
Grunental GmbH
Idenix Pharmaceuticals (2)
Ikaria
Impax Laboratories
Incyte Corporation
InterMune
Ironwood Pharmaceuticals (2)
Intrexon Corporation
Janssen R&D (2)
Johnson & Johnson (3)
Kadmon Corporation
Keryx Biopharmaceuticals (2)
Lantheus Medical Imaging
Lexicon Pharmaceuticals
MedImmune, Inc.
Medivation, Inc.
Merck & Company (8)
Merck Sharp & Dohme
Merck Animal Health
Millenium Pharmaceuticals
Mylan Pharmaceuticals
Neurocrine Biosciences
Novartis Pharmaceuticals (3)
NPS Pharmaceuticals
PTC Therapeutics (2)
Pfizer (7)
Pharmacyclics, Inc.
Purdue Pharma (2)
Rib-X Pharmaceuticals
Roche pRED China
Sanofi Aventis Deutschland
Sanofi Aventis USA
Sanofi Pasteur
Sartori Pharmaceuticals
Shionogi, Inc
Shire Pharmaceuticals
Sunovion Pharmaceuticals
Takeda San Diego, Inc
Tarsa Therapeutics
TetraPhase Pharmaceuticals (2)
Teva Pharmaceuticals (2)
Thervance
TransTech Pharma
Trius Therapeutics
UCB Pharma
United Therapeutics (5)
Vertex Pharmaceuticals